Ngā hua rapu - Nicholas C. Richardson

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma

    FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma mā Nicholas C. Richardson, Yvette L. Kasamon, Haiyan Chen, R. Angelo de Claro, Jingjing Ye, Gideon M. Blumenthal, Ann T. Farrell, Richard Pazdur

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies

    Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies mā Andrew D.J. Pearson, Elly Barry, Yaël P. Mossé, Franca Ligas, Nick Bird, Teresa de Rojas, Zachary Zimmerman, Keith D. Wilner, Willi Woessmann, Susan Weiner, Brenda J. Weigel, Rajkumar Venkatramani, D Valteau, Toby N. Trahair, Malcolm A. Smith, Sonia Singh, Giovanni Selvaggi, Nicole Scobie, Gudrun Schleiermacher, Nicholas C. Richardson, Julie Park, Karsten Nysom, Koen Norga, Margret Merino, Joe McDonough, Yousif Matloub, Lynley V. Marshall, Eric Lowe, Giovanni Lesa, Meredith S. Irwin, Dominik Karres, Amar Gajjar, François Doz, Elizabeth Fox, Steven G. DuBois, Martha Donoghue, Michela Casanova, Hubert Caron, Victoria Buenger, Diana Bradford, P. Blanc, Amy Barone, Gregory H. Reaman, Gilles Vassal

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: